共同性外斜视内直肌IGF-Ⅰ、AnnexinA1的表达研究
|
摘要
目的观察共同性外斜视眼外肌中IGF-1、Annexin A1表达的变化,探讨IGF-1、Annexin A1在共同性外斜视发病机制中的作用。
方法收集我院2009-2010年收治的共同性外斜视病人(16例)为斜视组。根据年龄又将斜视组分为儿童斜视组(8例)和成人斜视组(8例)；同期行眼球摘除或角膜移植供体取得的水平直肌为成人对照组(共6例)。所有眼外肌固定切片后行IGF-1、Annexin A1免疫组织化学染色,测IGF-1、Annexin A1在眼外肌中的平均光密度值。对各组间平均光密度值进行比较,并对斜视患者眼外肌中IGF-1平均光密度值与患者斜视度及年龄进行相关性分析。
结果①IGF-1在斜视组、成人对照组、儿童斜视组及成人斜视组表达的平均光密度值分别为(0.225±0.041)、(0.334±0.024)、(0.255±0.012)及(0.196±0.038)。斜视组与成人对照组、儿童斜视组与成人斜视组、成人斜视组与成人对照组之间比较均有统计学意义(P<0.05)。②Annexin A1平均光密度值在斜视组、成人对照组、儿童斜视组及成人斜视组表达的平均光密度值分别为(0.148±0.031)、(0.254±0.050)、(0.197±0.027)及(0.126±0.026)。斜视组与成人对照组、儿童斜视组与成人斜视组、成人斜视组与成人对照组之间比较同样均有统计学意义(P<0.05)。③斜视患者IGF-1、AnnexinAl平均光密度值与患者的斜视度和年龄呈负相关(r=-0.721,P=0.002,r=-0.663,P=0.008；r=-0.554,P=0.029,r=-0.598,P=0.014)。
结论①眼外肌中IGF-1、Annexin A1表达的降低可能参与斜视的发病。②眼外肌中IGF-1、Annexin A1中的表达变化可能与斜视的发展相关。
Objective To investigate the expression of IGF-1 and Annexin 1 of extra ocular muscles (EOMs) in patients with concomitant extropia. To explore the role of IGF-1 and Annexin lin the etiology of concomitant extropia.
Methods Collect 16 cases accepted surgery with concomitant extropia and name strabismus group, then divided them into 2 groups which were the group of children with concomitant extropia and the group of adults with concomitant extropia. Medial rectus muscles were obtained with agreement from patients accepted surgical resection. Control muscles were obtained from patients with eyeballs removed with injury and corneal transplant donors. Cross sections were stained immunochemically and measured the mean optical density according to the expression of IGF-1 and Annexin 1 in EOMs. To compare the difference in different groups and analyze the relationship between the expression of IGF-1 and Annexin 1 and the age and the strabismus degree.
Results①We discovered IGF-1 and Annexin 1 expression in EOMs of strabismus group and control group. There were significant differences (P< 0.01) in the expression of IGF-1 and Annexin A1between the group of children with concomitant extropia and the group of adults with concomitant extropia, the control group and the group of adults with concomitant extropia, the group of adults with concomitant extropia and the strabismus group. The formers had higher level than the latters.②There were significant differences (P< 0.01) in the expression of IGF-1 and Annexin A1 between the strabismus group and the control group. And the former was lower than the latter.③There were negative relationship between IGF-1 and Annexin A1expression and prism diopter of deviation and patients' age.
Conclusion The decreased level of IGF-1 and Annexin 1 expression may participate in the incidence of concomitant extropia by inhibit the mechanism of self-renewal and repair; With age, the level of IGF-land Annexin A1 is down gradually, we consider it may be the cause of concomitant extropia with deteriorating process.
方法收集我院2009-2010年收治的共同性外斜视病人(16例)为斜视组。根据年龄又将斜视组分为儿童斜视组(8例)和成人斜视组(8例)；同期行眼球摘除或角膜移植供体取得的水平直肌为成人对照组(共6例)。所有眼外肌固定切片后行IGF-1、Annexin A1免疫组织化学染色,测IGF-1、Annexin A1在眼外肌中的平均光密度值。对各组间平均光密度值进行比较,并对斜视患者眼外肌中IGF-1平均光密度值与患者斜视度及年龄进行相关性分析。
结果①IGF-1在斜视组、成人对照组、儿童斜视组及成人斜视组表达的平均光密度值分别为(0.225±0.041)、(0.334±0.024)、(0.255±0.012)及(0.196±0.038)。斜视组与成人对照组、儿童斜视组与成人斜视组、成人斜视组与成人对照组之间比较均有统计学意义(P<0.05)。②Annexin A1平均光密度值在斜视组、成人对照组、儿童斜视组及成人斜视组表达的平均光密度值分别为(0.148±0.031)、(0.254±0.050)、(0.197±0.027)及(0.126±0.026)。斜视组与成人对照组、儿童斜视组与成人斜视组、成人斜视组与成人对照组之间比较同样均有统计学意义(P<0.05)。③斜视患者IGF-1、AnnexinAl平均光密度值与患者的斜视度和年龄呈负相关(r=-0.721,P=0.002,r=-0.663,P=0.008；r=-0.554,P=0.029,r=-0.598,P=0.014)。
结论①眼外肌中IGF-1、Annexin A1表达的降低可能参与斜视的发病。②眼外肌中IGF-1、Annexin A1中的表达变化可能与斜视的发展相关。
Objective To investigate the expression of IGF-1 and Annexin 1 of extra ocular muscles (EOMs) in patients with concomitant extropia. To explore the role of IGF-1 and Annexin lin the etiology of concomitant extropia.
Methods Collect 16 cases accepted surgery with concomitant extropia and name strabismus group, then divided them into 2 groups which were the group of children with concomitant extropia and the group of adults with concomitant extropia. Medial rectus muscles were obtained with agreement from patients accepted surgical resection. Control muscles were obtained from patients with eyeballs removed with injury and corneal transplant donors. Cross sections were stained immunochemically and measured the mean optical density according to the expression of IGF-1 and Annexin 1 in EOMs. To compare the difference in different groups and analyze the relationship between the expression of IGF-1 and Annexin 1 and the age and the strabismus degree.
Results①We discovered IGF-1 and Annexin 1 expression in EOMs of strabismus group and control group. There were significant differences (P< 0.01) in the expression of IGF-1 and Annexin A1between the group of children with concomitant extropia and the group of adults with concomitant extropia, the control group and the group of adults with concomitant extropia, the group of adults with concomitant extropia and the strabismus group. The formers had higher level than the latters.②There were significant differences (P< 0.01) in the expression of IGF-1 and Annexin A1 between the strabismus group and the control group. And the former was lower than the latter.③There were negative relationship between IGF-1 and Annexin A1expression and prism diopter of deviation and patients' age.
Conclusion The decreased level of IGF-1 and Annexin 1 expression may participate in the incidence of concomitant extropia by inhibit the mechanism of self-renewal and repair; With age, the level of IGF-land Annexin A1 is down gradually, we consider it may be the cause of concomitant extropia with deteriorating process.
引文
[1]Govindan M, Mohney BC, Diehl NN, et al. Incidence and types of childhood exotropia: a population-based study. Ophthalmology,2005.112:104-108.
[2]Pennefather PM, Tin W. Ocular abnormalities associated with cerebral palsy after preterm birth. Eye,2000,14(Pt 1):78.
[3]陈永东,刘双珍,吴小影等.共同性斜视眼外肌神经生长因子的表达与形态结构改变的关系.中国斜视与小儿眼科杂志.2004,12(2)：66-68.
[4]陈丽英,徐国英,梁平等.共同性外斜视眼外肌超微病理研究.眼科.2000,9(1)：46.
[5]郭自元.共同性斜视眼外肌病理分析[J].中国斜视与小儿眼科杂志,2007,15：129-131.
[6]宋卫红,汤长发,王良春.肌卫星细胞分化与骨骼肌纤维改变[J].中国组织工程研究与临床康复,2007,11(41)：8340-8344.
[7]McLoon LK, W' mschatk JD. Continuous myonucleaz addition to single extraocular myofibets in uninjured adult rabbits. Muscle Nerve,2002,25:348-358.
[8]McLoon LK,Wmschaftar JD. Aetivated satellite cells are present in uninjured extraocular muscles of mature mice. Trans Am Ophthalmol Soc,2002,100:119-124.
[9]McLoon LK, Wirtschaf ter J. Activated Satellite Cells in Extraocular Muscles of Normal Adult Monkeys and Humans. Invest Ophthalmol Vis Sci.2003;44:1927-1932.
[10]Antunes-Foshini RMS, Ramalho RS. Increased frequency of activated satellite cells in overacting inferior oblique muscles from humans[J]. Invest Opthalmol Vis Sci,2006,47:3360-3365.
[11]王雪.麻痹性上斜视功能亢进的下斜肌形态结构改变及活性卫星细胞表达的研究[D].长沙：中南大学,2007：9-11.
[12]Clemmons DR,Moses AC,Mckay MJ, et al. The combination of insulin-like growth factor-I and insulin-like growth factor binding protein-3 reduces insulin requirements in insulin-dependent type 1 diabetes:evidence for in vivo biological activity. J Clin Endoerinol Metab,2000,85:151.
[13]Bhuyan DK, Reddy PG, Bhuyan KC. Growth factor receptor gene and protein expressions in the human lens. MechAgeing Dev.2000,113(3):205-18
[14]Cao Y, W ei H, Da B, et al. Insulin-like growth factor-I gene cloning and protein expression in bovine trabecular meshwork tissue and cells. J Huazhong Univ Sci Technolog Med Sci 2002;22(1):69-72.
[15]Ando A, Kaneko S, Matsumura M. The effect of growth factors on the proliferation of cultured porcine trabecular meshwork cells. Nippon Ganka Gakkai Zasshi 2004; 108(9):549-553.
[16]Sim6 R, Carrasco E, Garcfa-Remfrez,et al. Angiogenic and antiangiogenic factors in proliferative diabetic retinopathy[J]. Curr Diabetes Rev.2006,2(1):71-98.
[17]Jennische E, Skottner A, Hansson HA, et al. Satellite cells express the trophic factor IGF2I in regenerating skeletal muscle. Acta Physiol Scand 1987,129:9.
[18]Levinovitz A, Jennische E, Oldfors A, et al. Activation of insulin-like growth factor-II expression during skeletal muscle regeneration in the rat:correlation with myotube formation. Mol Endocrinol,1992,6:12-7.
[19]向峥,等.胰岛素样生长因子-Ⅰ在大鼠骨骼肌运动性损伤卫星细胞再生中的作用[J].中华创伤骨科杂志,2004,6(7)：801-804.
[20]Menetrey J, Kasemkilwattana C, Day CS, et al. Growth factors improve muscle healing in vivo [J].Bone and Joint Surgery-British Volume,2000,82B(1):131-137.
[21]Anderson BC, Christiansen SP, Grandt S, et al. Increased Extraocular Muscle Strength with Direct Injection of Insulin-like Growth Factor-I. Invest Ophthalmol Vis Sci. 2006:47:2461-2467.
[22]许金玲,余新平,陈洁,等.眼外肌局部注射IGF-I的组织学变化.眼科研究,2009,27(6)：477-480.
[23]McLoon LK, Anderson BC, Christiansen SP. Increasing muscle strength as a treatment for strabismus:sustained release of insulin-like growth factor-1 in rabbit extraocular muscle. J AAPOS 2006;10 (5):424-429.
[24]Kelly P. J et al. Somatomedin C physical fitness and bone density. J Clin EndicrinolMetab,1990,70:718.
[25]Barton-Davis ER, Shoturma DI, Musaro A, et al. Viral mediated expression of insulin21ike growth factor I blocks the aging-related loss of skeletal muscle fuction. Proc Natl Acad Sci USA 1998,95:15603.
[26]Renganathan M, Messi ML, Delbono 0, et al. Overexpressiom of IGF-I exclusively in skeletal muscle prevents age-related decline in the number of dihydropyridine receptors. J Biol Chem 1998,273(44):28-45.
[27]Gerke V, Moss SE. Annexins:from structure to function[J].Physio Rev,2002,82(10):331
[28]Croxtall, J., Flower, R., Perretti, M. (1993) The role of lipocortin 1 in the regulation of A549 cell proliferation and leukocyte migration. J. Lipid. Mediat. 6,295-302.
[29]De Coupade, C., Gillet, R., Bennoun, M., Briand, P., Russo-Marie, F., Solito, E. (2000) Annexin 1 expression and phosphorylation are upregulated during liver regeneration and transformation in antithrombin III SV40 T large antigen transgenic mice. Hepatology 31,371-380.
[30]Skouteris GG, Schroder CH. The hepatocyte growth factor receptor kinase-mediated phosphorylation of lipocortin-1 transduces the proliferating signal of the hepatocyte growth factor [J]. J Biol Chem,1996,271(44):27-66.
[31]McKanna JA. Lipocortin 1 in apoptosis:mammary regression. Anat Record 1995; 242:1-10.
[32]Sakamoto T, Repasky WT, Uchida K, Hirata A, Hirata F. Modulation of cell death pathways to apoptosis and necrosis of H202-treated rat thymocytes by lipocortin I. Biochem Biophys Res Commun 1996,220:643-7.
[33]SolitoE, de Coupade C, Canaider S, Goulding NJ, Perretti M. Transfection of annexin 1 in monocytic cells produces a high degree of spontaneous and stimulated apoptosis associated with caspase-3 activation. Br J Pharmacol 2001;133:217-28.
[34]Debret R, E1 Btaouri H, Duca L, Rahman I, Radke S, Haye B, et al. Annexin Al processing is associated with caspase-dependent apoptosis in BZR cells. FEBS Lett 2003:546:195-202.
[35]Solito E, Kamal A, Russo-Marie F, Buckingham JC, Marullo S, Perretti M. A novel calcium dependent pro-apoptotic effect of annexin I on human neutrophils. FASEB J 2003;17:1544-56.
[36]Parente L, Solito E. Annexin 1:more than an anti-phospholipase protein[J]. inflamm Res,2004,53(2):125-132.
[37]Anna K. McNeil, Ursula Rescher, Volker Gerke, et al. Requirement for Annexin Al in Plasma Membrane Repair. [J].Biochem.2006,281(46) pp.35202-35207.
[38]McNeil, P. L., and Terasaki, M. (2001) Nat. Cell Biol.3, E124-E129
[39]Petrof, B. J., Shrager, J. B., Stedman, H. H., Kelly, A. M., and Sweeney, H. L. (1993) Proc. Natl. Acad. Sci. U. S. A.90,3710-3714
[40]Bansal, D., Miyake, K., Vogel, S. S., Groh, S., Chen, C. C., Williamson, R., McNeil, P. L., and Campbell, K. P. (2003) Nature 423,168-172
[41]Lennon NJ, Kho A, Bacskai BJ, Perlmutter SL, Hyman BT, Brown RH, Jr.2008. Dysferlin interacts with annexin A1 and A2 and mediates sarcolemmal wound-healing. J Biol Chem.50:50466-50473.
[42]Bizzarro V, Fontanella B, Franceschelli S, et al. Role of Annexin Al in mouse myoblast cell differentiation. J Cell Physiol.2010,224(3):757-65.
[1]Simpsou LL, The origin, structures and pharmacological activity of botulinum toxin[J]. Pharmacol Rev.1981,33:155-188.
[2]Magoon E. H. Chemodenervalion of Strabismil children. Ophthalmology[J].1989,96:9 31.
[3]Huang W.Foster JA, Rogachefsky AS. Pharmacology of botulinum toxin[J].J Am Acad Dermatol,2000,43:249-259.
[4]邓宏伟,杨景存,曹木荣,等,眼外肌注射肉毒杆菌毒素A后的形态学改变[J].眼科研究,2000,18(2)：140-142.
[5]闰丽娟,吴晓.眼外肌注射A型肉毒毒素后神经萌芽及运动终板的变化[J].眼科,2006,15：326.331.
[6]Kranjc, BS. Sketelj J, D'Albis A, et al. Long-term changes in myosin heavy chain composition after botulinum toxin A injection into rat rectus muscle[J].Invest Ophthalmol Vis Sci,2001,42(13):3158-3164.
[7]Ing MR, Bolulinum alignment for congenital esotropia[J]. Ophothalmologyl 1993,100: 3181.
[8]娄小波,代守,李应钊,等.肉毒杆菌毒素在眼科应用[J].中国斜视与小儿眼科杂志,2005,13(4)：173-174.
[9]Alba Campomanes AG, Binenbaum G, Campomanes Equiarte G. Comparision of Botulinum toxin with surgery as primary treatment for infantile esotropia[J]. JAAPOS,2010, 14(2):111-6.
[10]McNeer KW, Tucker MG Spencer RF. Management of essential infantile esotropia with botulinum toxinA:review and recommendations[J].J Pediatr Ophthalmol Strabismus 2000,37:63-67
[11]房学军,孙一凡.A型肉毒杆菌毒素在治疗斜视中的应用[J].中国实用眼科杂志2002：20(9)：643-644.
[12]吴晓.A型肉毒杆菌毒素治疗斜视的远期疗效观察[J].中国斜视与小儿眼科杂志1996,4：100-104.
[13]颜建华,吴中耀.甲状腺相关眼病上睑退缩的治疗[J].眼视光学杂志,2005,7(1)：52-53.
[14]李苑,吴晓,王京辉.肉毒毒素治疗儿童间歇性外斜视的近期效果[J].眼科,2008,17：126-130.
[15]Liu M, Lee HC, Hertle RM, et al. Retinal detachment from inadvertent intraocular injection of botulinum toxin A[J]. Am J, Ophthalmol,2004,137:201-202.
[16]Hott JS, lakas MC. eletal muscle-pecif ic immunotoxin for the reatment of focal muscle spasm[J]. Neurology,1998,50:485-491.
[17]Philip J, et al. Structure and activity of an active site substitution of Ricin A chain[J]. Biochemistry,1996,35:11098-11103.
[18]苏雅拉图,黄凤兰,张继星,等.蓖麻毒蛋白的研究进展[J].内蒙古民族大学学报.2010,25(4)：419-422.
[19]Stephen P. Christiansen, Daniel Peterson, Thu To,et al. Long-term Effects of Ricin-mAb 35 on Extraocular Muscles of Rabbits:Potential Treatment for strabismus [J]. IOVS,2002,43 (3):679-685.
[20]Christiansen SP, Becker BA, Laizzo PA, et al. Extraocular muscle force generation after ricin-mAb35 injection:implications for strabismus treatment[J]. JAAPOS, 2003,7:1-6.
[21]Stephen P. Christiansen, Amy Sandnas, Robert Prill, et al. Acute effect of the skeletal muscle-specific immunotoxin Ricin-mAb 35 on extrocular muscles of rabbits [J]. Invest Ophthalmol Vis Sci.2000,41(11):3402-9.
[22]SP Christiansen, B Anderson, LK McLoon. Combining ricin-mAb35 and botulinum toxin to weaken extraocular muscle[J]. Invest Ophthalmol Vis Sci,2006,47:5395-5401.
[23]Stephen P. Christiansen, MD, Brian C. Anderson, et al. Botulinum toxin pretreatment augments the weakening effect of injection with ricin-mAb35 in rabbit extraocular muscle[J]. JAAPOS.2008,12(2):122-127.
[24]Holds JB, Alderson K, Fogg SG, et al. Motor nerve sprouting in human obicularis oculi musle after botulinum A injection. Invest Ophthalmol Vis Sci.1990,31:964-967.
[25]Stephen P. Christiansen, Daniel Peterson, Thu To,et al. Long-term Effects of Ricin-mAb 35 on Extraocular Muscles of Rabbits:Potential Treatment for Strabismus[J]. IOVS,2002,43 (3):679-685.
[26]Libelius R, Sonesson B, Stamenovic BA. Denervation-like changes in skeletal muscle after treatment with a local anesthetic (MarcaineR). JA nat,1970,106(2):297.
[27]Bradley WG. Muscle fiber splitting. In:Mauro A,ed. Muscle Regeneration. New York:Raven Press; 1979:215-232.
[28]吴海涛,陈晓萍.盐酸布比卡因、透明质酸酶对大鼠在体肌卫星细胞增殖的影响[J]. Chin J Phvsiol,2003,19:378-383.
[29]邢国刚,宋新爱,樊小力等,布比卡因对肌梭的损害作用[J].西北药学杂志,2000,15(4),160-161.
[30]Hall-Craggs EC. Early ultrastructural changes in skeletal muscle exposed to local anaesthetic bupivacaine (marcaine). Br J Exp Pathol 1980a.60139-149.
[31]Bradley W G. Muscle fiber spiliting. In:Mauro A, ed. Muscle regeneration. New York: Raven Press,1979,215-232.
[32]Rosenblatt J D, Woods R I. Hypertrophy of rat extensor digitorum longus muscle injected with bupivacaine. A sequential histochemical, immunohistochemical, histochemical, immunohistochemical, histological and morphometric study. J Anat 1992,18111-27.
[33]David R.Plant, Felice Beitzel. Length-tension relationships are altered in regenerating muscles of the rat after bupivacaine injection[J]. J Appl Physiol,2005, 98:1998-2003.
[34]Choul Yong Park. Acute effect of bupivacaine and ricin-mAb35 on extraocular muscle in the rabbit[J]. Current Eye Research,2004,9:93-301
[35]Han S K, Kim J H, Hwang J M. Persistent diplopia after retrobulbar anesthesia[J]. J Cataract Refract Surg 2004.301248-1253.
[36]BY Alan B, Scott MD, Joel M. Miller PhD, et al. Treating strabismus by injecting the agonist muscle with bupivacaine and the antagonist with botulinum toxin[J]. Trans Am Ophthalmol Soc,2009,107:104-111
[37]Wutthiphan S, Srisuwanporn S. Bupivacaine injection to treat extropia and esotropia [J]. Strabismus,2010,18(4):137-41
[38]Amthor H, Christ B, Weil M, Patel K. The importance of timing differentiation during limb muscle development. Curr Biol.1998;8:642-645.
[39]Tzahor E, Kempf H, Mootoosamy RC, et al. Antagonists of Wnt and BMP signaling promote the formation of vertebrae head muscle. Genes Dev.2003;17:3087-3099.
[40]Suryawan A, Frank JW, Nguyen HV, Davis TA. Expression of the TGFb family of ligands is developmentally regulated in skeletal muscle of neonatal rats. Pediatr Res. 2006;59:175-179.
[41]Allen RE, Boxhorn LK. Inhibition of skeletal muscle satellite cell differentiation by transforming growth factor-beta. J Cell Physiol.1987; 133:Physiol. 1987;133:567-572.
[42]Grainger DJ, Kemp PR, Witchell CM, Weissberg PL, Metcalfe JC. Transforming growth factor beta decreases the rate of proliferation of rat vascular smooth muscle cells by extending the G2 phase of the cell cycle and delays the rise in cAMP before entry into M phase. Biochem J.1994;299:227-235.
[43]Chen YW, Nagaraju K, Bakay M, et al. Early onset of inflammation and later involvement of TGFbeta in Duchenne muscular dystrophy. Neurology.2005;65:826-834.
[44]Budasz-Rwiderska M, Jank M, Motyl T. Transforming growth factor-betal upregulates myostatin expression in mouse C2C12 myoblasts. J Physiol Pharmacol.2005;56:195-214.
[45]Brian C. Anderson, Stephen P. Christiansen, Linda K. McLoon. Myogenic Growth Factors Can Decrease Extraocular Muscle Force Generation:A Potential Biological Approach to the Treatment of Strabismus[J]. Invest Ophthalmol Vis Sci.2008,49(1):221-229.
[46]向峥,等.胰岛素样生长因子-Ⅰ在大鼠骨骼肌运动性损伤卫星细胞再生中的作用[J].中华创伤骨科杂志,2004,6(7)：801-804.
[47]Menetrey J, Kasemkilwattana C, Day CS, et al. Growth factors improve muscle healing in vivo [J].Bone and Joint Surgery-British Volume,2000,82B (1):131-137.
[48]程昌志.胰岛素样生长因子-1基因转染对大鼠肌腱细胞生长的促进作用[J].中华实验外科杂志,2004,21(1)：62-64.
[49]Anderson BC, Christiansen SP, Grandt S, et al. Increased Extraocular Muscle Strength with Direct Injection of Insulin-like Growth Factor-I. Invest Ophthalmol Vis Sci. 2006;47:2461-2467.
[50]许金玲,余新平,陈洁,等.眼外肌局部注射IGF-I的组织学变化.眼科研究,2009,27(6)：477-480.
[51]McLoon LK, Anderson BC. Christiansen SP. Increasing muscle strength as a treatment for strabismus:sustained release of insulin-like growth factor-1 in rabbit extraocular muscle. J AAPOS 2006,10(5):424-429.
[52]Linda K. McLoon, Stephen P. Christiansen. Increasing Extraocular Muscle Strength with Insulin-like Growth Factor II[J]. Invest Ophthalmol Vis Sci.2003;44:3866-3872.
[53]Zoico E,Roubenoff R. The role of cytokines in regulating protein metabolism and muscle function [J].Nutr Rev,2002,60:39-51.
[54]Peroulakis ME, Forger NG. Ciliary neurot rophic factor increases muscle fiber number in the developing levator ani muscle of female rats[J]. Neurosci Lett,2000,296:73-76.
[55]邓小华,侍坚,罗嗣琼等.睫状神经营养因子对大鼠去神经骨骼肌的营养作用[J].解剖学杂志,2001,24(2)128-131.
[56]闰丽娟,吴晓.睫状神经营养因子抗体对眼外肌注射肉毒毒素后神经末梢萌芽的影响[J]. Ophthalmol CHN,2008,17(5):323-326.
[57]刘欣春,朱悦,曹德寿. 碱性成纤维细胞生长因子和表皮生长因子对骨骼肌源性干细胞的 促增殖效应[J].中国修复重建外科杂志.2006,20(9)：936-939.
[58]Zhang Li-gui, Wa ng Chuan-fu, Huang Xiao-hui. Effect of basic fibroblast growth factor gene transfection on bio-behavior of rat extraocular muscle satellite cells[J]. Journal of Clinical Rehabilitative Tissue Engineering Research,2007,11 (33):6706-6711.
[59]Brian C. Anderson, Stephen P. Christiansen, Linda K. McLoon. Myogenic Growth Factors Can Decrease Extraocular Muscle Force Generation:A Potential Biological Approach to the Treatment of Strabismus[J]. Invest Ophthalmol Vis Sci,2008,49:221-229.
[60]刘欣春,朱悦,曹德寿.碱性成纤维细胞生长因子和表皮生长因子对骨骼肌源性干细胞的促增殖效应[J].中国修复重建外科杂志,2006,20(9)：936-939.
[61]程永丽.复方樟柳碱治疗麻痹性斜视的临床探讨[J].山西医药杂志,2010,39(11)：1079.
[62]谢文军,尚平,思健.正容复位汤治疗麻痹性斜视的临床研究[J].中国民族民间医药,2010,12(2)：167-169.
[63]刘萍萍,刘硕,于海泉.风牵偏视汤治疗麻痹性斜视[J].CJTOM,2010,22(12):1054.
[64]赵学勇,张凤梅.羌活胜风汤合牵正散结合针灸治疗麻痹性斜视[J].中国中医药,2010,8(15)：43-44.
[2]Pennefather PM, Tin W. Ocular abnormalities associated with cerebral palsy after preterm birth. Eye,2000,14(Pt 1):78.
[3]陈永东,刘双珍,吴小影等.共同性斜视眼外肌神经生长因子的表达与形态结构改变的关系.中国斜视与小儿眼科杂志.2004,12(2)：66-68.
[4]陈丽英,徐国英,梁平等.共同性外斜视眼外肌超微病理研究.眼科.2000,9(1)：46.
[5]郭自元.共同性斜视眼外肌病理分析[J].中国斜视与小儿眼科杂志,2007,15：129-131.
[6]宋卫红,汤长发,王良春.肌卫星细胞分化与骨骼肌纤维改变[J].中国组织工程研究与临床康复,2007,11(41)：8340-8344.
[7]McLoon LK, W' mschatk JD. Continuous myonucleaz addition to single extraocular myofibets in uninjured adult rabbits. Muscle Nerve,2002,25:348-358.
[8]McLoon LK,Wmschaftar JD. Aetivated satellite cells are present in uninjured extraocular muscles of mature mice. Trans Am Ophthalmol Soc,2002,100:119-124.
[9]McLoon LK, Wirtschaf ter J. Activated Satellite Cells in Extraocular Muscles of Normal Adult Monkeys and Humans. Invest Ophthalmol Vis Sci.2003;44:1927-1932.
[10]Antunes-Foshini RMS, Ramalho RS. Increased frequency of activated satellite cells in overacting inferior oblique muscles from humans[J]. Invest Opthalmol Vis Sci,2006,47:3360-3365.
[11]王雪.麻痹性上斜视功能亢进的下斜肌形态结构改变及活性卫星细胞表达的研究[D].长沙：中南大学,2007：9-11.
[12]Clemmons DR,Moses AC,Mckay MJ, et al. The combination of insulin-like growth factor-I and insulin-like growth factor binding protein-3 reduces insulin requirements in insulin-dependent type 1 diabetes:evidence for in vivo biological activity. J Clin Endoerinol Metab,2000,85:151.
[13]Bhuyan DK, Reddy PG, Bhuyan KC. Growth factor receptor gene and protein expressions in the human lens. MechAgeing Dev.2000,113(3):205-18
[14]Cao Y, W ei H, Da B, et al. Insulin-like growth factor-I gene cloning and protein expression in bovine trabecular meshwork tissue and cells. J Huazhong Univ Sci Technolog Med Sci 2002;22(1):69-72.
[15]Ando A, Kaneko S, Matsumura M. The effect of growth factors on the proliferation of cultured porcine trabecular meshwork cells. Nippon Ganka Gakkai Zasshi 2004; 108(9):549-553.
[16]Sim6 R, Carrasco E, Garcfa-Remfrez,et al. Angiogenic and antiangiogenic factors in proliferative diabetic retinopathy[J]. Curr Diabetes Rev.2006,2(1):71-98.
[17]Jennische E, Skottner A, Hansson HA, et al. Satellite cells express the trophic factor IGF2I in regenerating skeletal muscle. Acta Physiol Scand 1987,129:9.
[18]Levinovitz A, Jennische E, Oldfors A, et al. Activation of insulin-like growth factor-II expression during skeletal muscle regeneration in the rat:correlation with myotube formation. Mol Endocrinol,1992,6:12-7.
[19]向峥,等.胰岛素样生长因子-Ⅰ在大鼠骨骼肌运动性损伤卫星细胞再生中的作用[J].中华创伤骨科杂志,2004,6(7)：801-804.
[20]Menetrey J, Kasemkilwattana C, Day CS, et al. Growth factors improve muscle healing in vivo [J].Bone and Joint Surgery-British Volume,2000,82B(1):131-137.
[21]Anderson BC, Christiansen SP, Grandt S, et al. Increased Extraocular Muscle Strength with Direct Injection of Insulin-like Growth Factor-I. Invest Ophthalmol Vis Sci. 2006:47:2461-2467.
[22]许金玲,余新平,陈洁,等.眼外肌局部注射IGF-I的组织学变化.眼科研究,2009,27(6)：477-480.
[23]McLoon LK, Anderson BC, Christiansen SP. Increasing muscle strength as a treatment for strabismus:sustained release of insulin-like growth factor-1 in rabbit extraocular muscle. J AAPOS 2006;10 (5):424-429.
[24]Kelly P. J et al. Somatomedin C physical fitness and bone density. J Clin EndicrinolMetab,1990,70:718.
[25]Barton-Davis ER, Shoturma DI, Musaro A, et al. Viral mediated expression of insulin21ike growth factor I blocks the aging-related loss of skeletal muscle fuction. Proc Natl Acad Sci USA 1998,95:15603.
[26]Renganathan M, Messi ML, Delbono 0, et al. Overexpressiom of IGF-I exclusively in skeletal muscle prevents age-related decline in the number of dihydropyridine receptors. J Biol Chem 1998,273(44):28-45.
[27]Gerke V, Moss SE. Annexins:from structure to function[J].Physio Rev,2002,82(10):331
[28]Croxtall, J., Flower, R., Perretti, M. (1993) The role of lipocortin 1 in the regulation of A549 cell proliferation and leukocyte migration. J. Lipid. Mediat. 6,295-302.
[29]De Coupade, C., Gillet, R., Bennoun, M., Briand, P., Russo-Marie, F., Solito, E. (2000) Annexin 1 expression and phosphorylation are upregulated during liver regeneration and transformation in antithrombin III SV40 T large antigen transgenic mice. Hepatology 31,371-380.
[30]Skouteris GG, Schroder CH. The hepatocyte growth factor receptor kinase-mediated phosphorylation of lipocortin-1 transduces the proliferating signal of the hepatocyte growth factor [J]. J Biol Chem,1996,271(44):27-66.
[31]McKanna JA. Lipocortin 1 in apoptosis:mammary regression. Anat Record 1995; 242:1-10.
[32]Sakamoto T, Repasky WT, Uchida K, Hirata A, Hirata F. Modulation of cell death pathways to apoptosis and necrosis of H202-treated rat thymocytes by lipocortin I. Biochem Biophys Res Commun 1996,220:643-7.
[33]SolitoE, de Coupade C, Canaider S, Goulding NJ, Perretti M. Transfection of annexin 1 in monocytic cells produces a high degree of spontaneous and stimulated apoptosis associated with caspase-3 activation. Br J Pharmacol 2001;133:217-28.
[34]Debret R, E1 Btaouri H, Duca L, Rahman I, Radke S, Haye B, et al. Annexin Al processing is associated with caspase-dependent apoptosis in BZR cells. FEBS Lett 2003:546:195-202.
[35]Solito E, Kamal A, Russo-Marie F, Buckingham JC, Marullo S, Perretti M. A novel calcium dependent pro-apoptotic effect of annexin I on human neutrophils. FASEB J 2003;17:1544-56.
[36]Parente L, Solito E. Annexin 1:more than an anti-phospholipase protein[J]. inflamm Res,2004,53(2):125-132.
[37]Anna K. McNeil, Ursula Rescher, Volker Gerke, et al. Requirement for Annexin Al in Plasma Membrane Repair. [J].Biochem.2006,281(46) pp.35202-35207.
[38]McNeil, P. L., and Terasaki, M. (2001) Nat. Cell Biol.3, E124-E129
[39]Petrof, B. J., Shrager, J. B., Stedman, H. H., Kelly, A. M., and Sweeney, H. L. (1993) Proc. Natl. Acad. Sci. U. S. A.90,3710-3714
[40]Bansal, D., Miyake, K., Vogel, S. S., Groh, S., Chen, C. C., Williamson, R., McNeil, P. L., and Campbell, K. P. (2003) Nature 423,168-172
[41]Lennon NJ, Kho A, Bacskai BJ, Perlmutter SL, Hyman BT, Brown RH, Jr.2008. Dysferlin interacts with annexin A1 and A2 and mediates sarcolemmal wound-healing. J Biol Chem.50:50466-50473.
[42]Bizzarro V, Fontanella B, Franceschelli S, et al. Role of Annexin Al in mouse myoblast cell differentiation. J Cell Physiol.2010,224(3):757-65.
[1]Simpsou LL, The origin, structures and pharmacological activity of botulinum toxin[J]. Pharmacol Rev.1981,33:155-188.
[2]Magoon E. H. Chemodenervalion of Strabismil children. Ophthalmology[J].1989,96:9 31.
[3]Huang W.Foster JA, Rogachefsky AS. Pharmacology of botulinum toxin[J].J Am Acad Dermatol,2000,43:249-259.
[4]邓宏伟,杨景存,曹木荣,等,眼外肌注射肉毒杆菌毒素A后的形态学改变[J].眼科研究,2000,18(2)：140-142.
[5]闰丽娟,吴晓.眼外肌注射A型肉毒毒素后神经萌芽及运动终板的变化[J].眼科,2006,15：326.331.
[6]Kranjc, BS. Sketelj J, D'Albis A, et al. Long-term changes in myosin heavy chain composition after botulinum toxin A injection into rat rectus muscle[J].Invest Ophthalmol Vis Sci,2001,42(13):3158-3164.
[7]Ing MR, Bolulinum alignment for congenital esotropia[J]. Ophothalmologyl 1993,100: 3181.
[8]娄小波,代守,李应钊,等.肉毒杆菌毒素在眼科应用[J].中国斜视与小儿眼科杂志,2005,13(4)：173-174.
[9]Alba Campomanes AG, Binenbaum G, Campomanes Equiarte G. Comparision of Botulinum toxin with surgery as primary treatment for infantile esotropia[J]. JAAPOS,2010, 14(2):111-6.
[10]McNeer KW, Tucker MG Spencer RF. Management of essential infantile esotropia with botulinum toxinA:review and recommendations[J].J Pediatr Ophthalmol Strabismus 2000,37:63-67
[11]房学军,孙一凡.A型肉毒杆菌毒素在治疗斜视中的应用[J].中国实用眼科杂志2002：20(9)：643-644.
[12]吴晓.A型肉毒杆菌毒素治疗斜视的远期疗效观察[J].中国斜视与小儿眼科杂志1996,4：100-104.
[13]颜建华,吴中耀.甲状腺相关眼病上睑退缩的治疗[J].眼视光学杂志,2005,7(1)：52-53.
[14]李苑,吴晓,王京辉.肉毒毒素治疗儿童间歇性外斜视的近期效果[J].眼科,2008,17：126-130.
[15]Liu M, Lee HC, Hertle RM, et al. Retinal detachment from inadvertent intraocular injection of botulinum toxin A[J]. Am J, Ophthalmol,2004,137:201-202.
[16]Hott JS, lakas MC. eletal muscle-pecif ic immunotoxin for the reatment of focal muscle spasm[J]. Neurology,1998,50:485-491.
[17]Philip J, et al. Structure and activity of an active site substitution of Ricin A chain[J]. Biochemistry,1996,35:11098-11103.
[18]苏雅拉图,黄凤兰,张继星,等.蓖麻毒蛋白的研究进展[J].内蒙古民族大学学报.2010,25(4)：419-422.
[19]Stephen P. Christiansen, Daniel Peterson, Thu To,et al. Long-term Effects of Ricin-mAb 35 on Extraocular Muscles of Rabbits:Potential Treatment for strabismus [J]. IOVS,2002,43 (3):679-685.
[20]Christiansen SP, Becker BA, Laizzo PA, et al. Extraocular muscle force generation after ricin-mAb35 injection:implications for strabismus treatment[J]. JAAPOS, 2003,7:1-6.
[21]Stephen P. Christiansen, Amy Sandnas, Robert Prill, et al. Acute effect of the skeletal muscle-specific immunotoxin Ricin-mAb 35 on extrocular muscles of rabbits [J]. Invest Ophthalmol Vis Sci.2000,41(11):3402-9.
[22]SP Christiansen, B Anderson, LK McLoon. Combining ricin-mAb35 and botulinum toxin to weaken extraocular muscle[J]. Invest Ophthalmol Vis Sci,2006,47:5395-5401.
[23]Stephen P. Christiansen, MD, Brian C. Anderson, et al. Botulinum toxin pretreatment augments the weakening effect of injection with ricin-mAb35 in rabbit extraocular muscle[J]. JAAPOS.2008,12(2):122-127.
[24]Holds JB, Alderson K, Fogg SG, et al. Motor nerve sprouting in human obicularis oculi musle after botulinum A injection. Invest Ophthalmol Vis Sci.1990,31:964-967.
[25]Stephen P. Christiansen, Daniel Peterson, Thu To,et al. Long-term Effects of Ricin-mAb 35 on Extraocular Muscles of Rabbits:Potential Treatment for Strabismus[J]. IOVS,2002,43 (3):679-685.
[26]Libelius R, Sonesson B, Stamenovic BA. Denervation-like changes in skeletal muscle after treatment with a local anesthetic (MarcaineR). JA nat,1970,106(2):297.
[27]Bradley WG. Muscle fiber splitting. In:Mauro A,ed. Muscle Regeneration. New York:Raven Press; 1979:215-232.
[28]吴海涛,陈晓萍.盐酸布比卡因、透明质酸酶对大鼠在体肌卫星细胞增殖的影响[J]. Chin J Phvsiol,2003,19:378-383.
[29]邢国刚,宋新爱,樊小力等,布比卡因对肌梭的损害作用[J].西北药学杂志,2000,15(4),160-161.
[30]Hall-Craggs EC. Early ultrastructural changes in skeletal muscle exposed to local anaesthetic bupivacaine (marcaine). Br J Exp Pathol 1980a.60139-149.
[31]Bradley W G. Muscle fiber spiliting. In:Mauro A, ed. Muscle regeneration. New York: Raven Press,1979,215-232.
[32]Rosenblatt J D, Woods R I. Hypertrophy of rat extensor digitorum longus muscle injected with bupivacaine. A sequential histochemical, immunohistochemical, histochemical, immunohistochemical, histological and morphometric study. J Anat 1992,18111-27.
[33]David R.Plant, Felice Beitzel. Length-tension relationships are altered in regenerating muscles of the rat after bupivacaine injection[J]. J Appl Physiol,2005, 98:1998-2003.
[34]Choul Yong Park. Acute effect of bupivacaine and ricin-mAb35 on extraocular muscle in the rabbit[J]. Current Eye Research,2004,9:93-301
[35]Han S K, Kim J H, Hwang J M. Persistent diplopia after retrobulbar anesthesia[J]. J Cataract Refract Surg 2004.301248-1253.
[36]BY Alan B, Scott MD, Joel M. Miller PhD, et al. Treating strabismus by injecting the agonist muscle with bupivacaine and the antagonist with botulinum toxin[J]. Trans Am Ophthalmol Soc,2009,107:104-111
[37]Wutthiphan S, Srisuwanporn S. Bupivacaine injection to treat extropia and esotropia [J]. Strabismus,2010,18(4):137-41
[38]Amthor H, Christ B, Weil M, Patel K. The importance of timing differentiation during limb muscle development. Curr Biol.1998;8:642-645.
[39]Tzahor E, Kempf H, Mootoosamy RC, et al. Antagonists of Wnt and BMP signaling promote the formation of vertebrae head muscle. Genes Dev.2003;17:3087-3099.
[40]Suryawan A, Frank JW, Nguyen HV, Davis TA. Expression of the TGFb family of ligands is developmentally regulated in skeletal muscle of neonatal rats. Pediatr Res. 2006;59:175-179.
[41]Allen RE, Boxhorn LK. Inhibition of skeletal muscle satellite cell differentiation by transforming growth factor-beta. J Cell Physiol.1987; 133:Physiol. 1987;133:567-572.
[42]Grainger DJ, Kemp PR, Witchell CM, Weissberg PL, Metcalfe JC. Transforming growth factor beta decreases the rate of proliferation of rat vascular smooth muscle cells by extending the G2 phase of the cell cycle and delays the rise in cAMP before entry into M phase. Biochem J.1994;299:227-235.
[43]Chen YW, Nagaraju K, Bakay M, et al. Early onset of inflammation and later involvement of TGFbeta in Duchenne muscular dystrophy. Neurology.2005;65:826-834.
[44]Budasz-Rwiderska M, Jank M, Motyl T. Transforming growth factor-betal upregulates myostatin expression in mouse C2C12 myoblasts. J Physiol Pharmacol.2005;56:195-214.
[45]Brian C. Anderson, Stephen P. Christiansen, Linda K. McLoon. Myogenic Growth Factors Can Decrease Extraocular Muscle Force Generation:A Potential Biological Approach to the Treatment of Strabismus[J]. Invest Ophthalmol Vis Sci.2008,49(1):221-229.
[46]向峥,等.胰岛素样生长因子-Ⅰ在大鼠骨骼肌运动性损伤卫星细胞再生中的作用[J].中华创伤骨科杂志,2004,6(7)：801-804.
[47]Menetrey J, Kasemkilwattana C, Day CS, et al. Growth factors improve muscle healing in vivo [J].Bone and Joint Surgery-British Volume,2000,82B (1):131-137.
[48]程昌志.胰岛素样生长因子-1基因转染对大鼠肌腱细胞生长的促进作用[J].中华实验外科杂志,2004,21(1)：62-64.
[49]Anderson BC, Christiansen SP, Grandt S, et al. Increased Extraocular Muscle Strength with Direct Injection of Insulin-like Growth Factor-I. Invest Ophthalmol Vis Sci. 2006;47:2461-2467.
[50]许金玲,余新平,陈洁,等.眼外肌局部注射IGF-I的组织学变化.眼科研究,2009,27(6)：477-480.
[51]McLoon LK, Anderson BC. Christiansen SP. Increasing muscle strength as a treatment for strabismus:sustained release of insulin-like growth factor-1 in rabbit extraocular muscle. J AAPOS 2006,10(5):424-429.
[52]Linda K. McLoon, Stephen P. Christiansen. Increasing Extraocular Muscle Strength with Insulin-like Growth Factor II[J]. Invest Ophthalmol Vis Sci.2003;44:3866-3872.
[53]Zoico E,Roubenoff R. The role of cytokines in regulating protein metabolism and muscle function [J].Nutr Rev,2002,60:39-51.
[54]Peroulakis ME, Forger NG. Ciliary neurot rophic factor increases muscle fiber number in the developing levator ani muscle of female rats[J]. Neurosci Lett,2000,296:73-76.
[55]邓小华,侍坚,罗嗣琼等.睫状神经营养因子对大鼠去神经骨骼肌的营养作用[J].解剖学杂志,2001,24(2)128-131.
[56]闰丽娟,吴晓.睫状神经营养因子抗体对眼外肌注射肉毒毒素后神经末梢萌芽的影响[J]. Ophthalmol CHN,2008,17(5):323-326.
[57]刘欣春,朱悦,曹德寿. 碱性成纤维细胞生长因子和表皮生长因子对骨骼肌源性干细胞的 促增殖效应[J].中国修复重建外科杂志.2006,20(9)：936-939.
[58]Zhang Li-gui, Wa ng Chuan-fu, Huang Xiao-hui. Effect of basic fibroblast growth factor gene transfection on bio-behavior of rat extraocular muscle satellite cells[J]. Journal of Clinical Rehabilitative Tissue Engineering Research,2007,11 (33):6706-6711.
[59]Brian C. Anderson, Stephen P. Christiansen, Linda K. McLoon. Myogenic Growth Factors Can Decrease Extraocular Muscle Force Generation:A Potential Biological Approach to the Treatment of Strabismus[J]. Invest Ophthalmol Vis Sci,2008,49:221-229.
[60]刘欣春,朱悦,曹德寿.碱性成纤维细胞生长因子和表皮生长因子对骨骼肌源性干细胞的促增殖效应[J].中国修复重建外科杂志,2006,20(9)：936-939.
[61]程永丽.复方樟柳碱治疗麻痹性斜视的临床探讨[J].山西医药杂志,2010,39(11)：1079.
[62]谢文军,尚平,思健.正容复位汤治疗麻痹性斜视的临床研究[J].中国民族民间医药,2010,12(2)：167-169.
[63]刘萍萍,刘硕,于海泉.风牵偏视汤治疗麻痹性斜视[J].CJTOM,2010,22(12):1054.
[64]赵学勇,张凤梅.羌活胜风汤合牵正散结合针灸治疗麻痹性斜视[J].中国中医药,2010,8(15)：43-44.